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Of7,000 landfills nationwide, the EPA
estimates the rule will affect up to 280.
Total costs nationwide are estimated at
$778 million in one-time capital costs and
$93 million annually, which the EPA esti-
mates will translate into customer costs
between $0.20 and $0.40 monthly. These
customer costs could be offset by landfills
selling the energy generated through the
recovery systems.
Industry representatives are generally
supportive ofthe new rule. "Lots ofprivate
landfills are already collecting methane,
and this will just require more fine-tun-
ing," said Ed Repa, director of environ-
mental programs for the National Solid
Waste Management Association.
"It's a workable rule," said Chris Voell,
director of technical services for the Solid
Waste Association of North America,
"though, as a direct public health concern,
we don't think EPA had all the data they
needed to say methane has an impact on
health."
For small landfills, defined
as those that accept 20 tons of
solid waste or less per day,
amendments to the Solid Waste
Disposal Act, signed into law on
March 26, could mean less
stringent regulations. One pro-
vision, authored by Senator Pete
Domenici (R-New Mexico),
requires the EPA to develop
guidelines that afford states flex-
ibility in regulating small land-
fills while still protecting human
health and the environment.
The guidelines, which must
be developed within two years,
will address four areas: frequen-
cy ofcover application, frequen-
cy of monitoring, infiltration
layers for final cover, and means
ofdemonstrating financial assur-
ance. Domenici's office said
that, while states currently have
a good deal of flexibility to
design solid waste regulations to
fit local needs, the rules in these
four areas are too rigid.
According to EPA staff, the cur-
rent rules require landfill opera-
tors to cover solid waste with
dirt every day, monitor methane
on a quarterly basis, install a
final cover of24 inches ofearth-
en material, and be able to
demonstrate they have the
money to provide closure and
post-closure care for the landfill.
The amendments will likely only
apply to landfills in dry, remote
areas, according to the EPA,
where groundwater contamination is less
ofa potential problem.
Another provision in the amendments
exempts small landfills from groundwater
monitoring requirements if they are locat-
ed in an area that receives less than 25
inches ofprecipitation annually, unless the
state finds such monitoring necessary to
protect groundwater resources. An earlier
EPA attempt to create this exemption by
regulation was overturned by the U.S.
Circuit Court ofAppeals for the District of
Columbia, which found the agency did not
have authority to issue the exemption.
"The irony is, a landfill's not eligible
for the exemption if you have evidence of
groundwater contamination, but without
groundwater monitoring you can only
prove the contamination if it shows up in
someone's well," said David Lennett, an
attorney who has represented the NRDC.
Proponents of the small-landfill mea-
sures say they are necessary because the
stringent requirements for large landfills in
some cases are simply unnecessary-and
unaffordable-for small landfills in arid
climates. For example, the New Mexico
Environment Department estimates
Domenici's provision could save the state
$50 million over the next 10 years.
"It's just adding some common sense
to the process," said Tom Kennedy, execu-
tive director ofthe Association ofState and
Territorial Solid Waste Management
Officials. If an area doesn't get enough
rainfall to create leachate, measures aimed
at reducing and monitoring leachate are
not needed, he said.
However, other industry groups remain
skeptical. "It doesn't make sense from a pub-
lic health perspective," Repa said. "It is in
arid, remote areas where people are drinking
groundwater from wells, rather than mun-
icipal treatment systems," he said. "So it
makes sense to require monitoring wells
there." Repa estimated the cost of installing
a monitoring well to be about $4,000, plus
an annual $1,000 to monitor it. "Ifyou look
at the cost, it's small compared
to remediation," he said.
"Subtitle D [ofthe Resource
Conservation and Recovery
Act] was supposed to close
down the small landfills, and
create larger ones with more
environmental protections
through economy of scale,"
Repa said. "This [exemption]
would allow the status quo at
those smaller facilities." However,
according to Domenici's office,
in large states like New Mexico,
consolidation of small landfills
may not always be a cost-effec-
tive option.
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Working outside the cell? Micrographs (A, B, and C in successively higher mag-
nifications) showing granules apparently secreting BRCA1 protein outside the cell
suggest that it may be possible to design drugs to mimic the protein's effects.
Source: Jensen RA et. al., BRCA1 is secreted and exhibits properties of a granin.
Nature Genetics, 12:303-308, (1996).
Using BRCA1 to Treat
Cancer
In the two years since the gene
for inherited breast cancer,
BRCAI, was identified, research-
ers have been trying to under-
stand how the gene normally
works. A team from Vanderbilt
University and the University of
Washington has now shown
that BRCA1 suppresses the for-
mation and growth of breast
tumors in mice. Their results,
published in the March issue of
Nature Genetics, suggest that the
gene or drugs that mimic its
protein product might someday
be used to treat human breast
and ovarian cancer.
"This iswhat everybody had
hoped-that there would be a
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gene found that actually would retard the
development ofbreast tumors-and it seems
to do that," said Anne Bowcock, a breast
cancer researcher and associate professor of
pediatrics at the University of Texas
Southwestern Medical Center in Dallas. "I
think it's a significant step toward the treat-
ment of at least some breast cancers." Most
ofthe 184,000 new breast cancer cases diag-
nosed annually are not the inherited type.
But the new research suggests that the pro-
tein produced by normal BRCA1 genes may
be effective against the more common non-
inherited forms ofbreast cancer.
Researchers led by Jeffrey Holt of
Vanderbilt first implanted normal BRCA1
genes into human breast and ovarian cancer
cells and found that cell growth was inhibit-
ed in vitro. Next, the researchers stably trans-
ferred either normal or mutant BRCA1 genes
into breast cancer cells and injected the cells
into mice. Tumors developed in all 15 mice
given mutant BRCA1, but in none ofthe 20
mice given normal BRCAI. Finally, the
researchers injected viruses carrying the
BRCA1 gene into the abdomens of 10 mice
with established breast cancer tumors; half
the mice got normal BRCA1, the others got
mutated BRCA1. The mice with mutant
BRCA1 all died ofcancer within two weeks.
Those with normal BRCA1 survived 15 to
41 days, and their tumors either shrank or
disappeared.
All the experiments used a cell line
derived from noninherited breast cancer, sug-
gesting that the treatment might work
against the more common types of the dis-
ease. Against hereditary breast and ovarian
cancer, "presumably it would have an even
more dramatic effect-at least that's what we
hope," said RoyJensen, an assistant professor
ofpathologyand cell biology atVanderbilt.
Translating the results into treatments
for human cancers will take time. "It's going
to be a long time before this is taken to the
bedside," said Bowcock. "The problem is
actually getting BRCA1 into breast cells-it's
not going to be easy."
It's easier to get BRCA1 into ovarian
tumor cells, and Vanderbilt researchers
recently began clinical trials using BRCA1 on
about 20 ovarian cancer patients, a move
that concerns some of their colleagues.
While he finds the results ofthe mouse and
cell culture experiments "intriguing" and
"encouraging," Roger Wiseman, head ofthe
Comparative Carcinogenesis Group of the
NIEHS Laboratory of Molecular
Carcinogenesis (part ofthe team that identi-
fied BRCA1) feels the human gene therapy
trials are "premature, based on the data that
have been presented so far." Wiseman would
like to see more animal studies performed
before BRCAJ is used in patients.
A related study led by Jensen found evi-
dence that the BRCA1 protein may be
secreted and do its work outside the cell. If
this is true, it would be much easier to
design and deliver drugs that mimic the pro-
tein's effects. However, this finding is con-
troverted, and other research groups are con-
vinced that the BRCA1 protein works from
inside cells.
"What we need to do to confirm our
theory is purify recombinant BRCAJ and
put it onto cells and see if it actually has a
growth inhibitory action," said Jensen. If it
does, and if it works only on breast and
ovarian cancer cells and not other cells,
"then that's pretty good evidence that there
are specific receptors for this protein. Our
efforts then would be focusing on trying to
find those receptors."
Fueling the Gas Debate
New findings continue to fuel the debate
over the safety and effectiveness of gasoline
additives, such as methyl tertiary butyl ether
(MTBE) and ethanol, being used to reduce
air pollution. The Clean Air Act
Amendments of 1990 required that, begin-
ning in 1992, areas that fail to meet air qual-
ity standards must use oxygenated fuels. Not
only has the effectiveness of the oxygenates
in reducing carbon monoxide (CO) emis-
sions been questioned, the additives have
also been accused ofcausing health problems
including headaches, dizziness, nausea, and
rashes. However, a recent study has found
that the additives are successful in reducing
CO emissions and do not appear likely to
substantially increase health risks when com-
pared to normal gasoline. The report
Genetics and Biosafety
With the pounding pace at which research in genetics and biotechnology is progressing, it
has become increasingly difficult forscientists to stayabreast ofall the advances and ensure
that the new technology is being used in a safe and cautious manner. In an effort to
improve communications among scientists and promote the safe use ofbiotechnology, the
United Nations established the International Centre for Genetic Engineering and
Biotechnology (ICGEB).
The center maintains two main research laboratories, one in Trieste,
Italy, and another in New Delhi, India, with several other smaller labs scat-
tered around the world. These laboratories distribute their findings along
with other biology-related information over the Internet via the ICGEB
home page and ICGEBnet, an information resource network for molecular
biologists.
The ICGEB home page, located athttpdJ/bascicgeb.trieit/, provides
information on ICGEB-sponsored meetings and symposia, access to biology-
related databases and newsgroups, and information on accessing ICGEBnet. 3)
Asecond biology-related network available from the home page called BIN21 is still being
developed bytheICGEB andwill focus on issues ofbiodiversity.
Among the databases accessible from the ICGEB's home page is one relating to P450
proteins and P450-containing systems, an on-line directory ofbiologists around theworld,
and SBASE (a sequence database ofprotein domains). An extensive library of biosafety-
related rules andregulations fromvarious nations, organizations, and research institutions is
also available, along with lists of experts and databases that can be contacted to help
researchers in dealing with biology-related legal issues. For further assistance on biosafety
and legal questions, a link is provided to the Stockholm Environment Institute's
Biotechnology Advisory Board home page. This international board of scientists will
answer questions and give advice on any issue relating to ecology, biochemistry, genetics,
biotechnology, pathology, environmental law, oreconomics.
Access to ICGEBnet andBIN21 will be free ofcharge butgenerally limited to scientists
andpolicymakers with apertinent interest in biology. Currently, ICGEBnet gives scientists
around theworld access to avarietyofdatabases andprovides acomputer environment that
allows molecular biologists to analyze nudeotide and protein sequences. Analysis software,
induding three major program packages, is distributed over ICGEBnet. In addition, infor-
mation services such as electronic mail and bulletin boards are also available. The center's
goal is to distribute these services to areas ofthe developing world where they are not yet
widelyavailable.
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